RxDoctor Payments DataLook up a doctor →

Ravi Bhagwat, MD

Cardiovascular Disease · Munster, INNPI 1386694230

Payments from drug & device makers

$2,176,630in general payments, 2019–2025

Across 1,429 payments — averaging $1523.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$527K
  • Merck$494K
  • AstraZeneca$472K
  • Novartis$277K
  • Novo Nordisk AS$142K
  • Novo Nordisk$81K
  • plus $184K from 48 others
$1,202in research payments, 2019–2025

Across 1 payment — averaging $1201.52 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$1K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,176,630 in reported general payments places this provider in the 95th percentile of 408 cardiovascular disease providers in Indiana.

See all cardiovascular disease providers in Indiana

Medicare billing

Part B allowed, 2024
$595,779
Medicare patients
826
Services billed
5,493

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other cardiovascular disease in Munster

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →